DrugPatentWatch Database Preview

Details for Patent: 8,026,279

« Back to Dashboard

Which drugs does patent 8,026,279 protect, and when does it expire?

Patent 8,026,279 protects HORIZANT and is included in one NDA.

This patent has twenty-nine patent family members in twenty-two countries.

Summary for Patent: 8,026,279

Title:	Crystalline form of .gamma.-aminobutyric acid analog
Abstract:	A crystalline form of a .gamma.-aminobutyric acid analog, and methods of preparing same, are provided.
Inventor(s):	Estrada; Tono (Santa Clara, CA), Raillard; Stephen P. (Mountain View, CA)
Assignee:	XenoPort, Inc. (Santa Clara, CA)
Application Number:	10/966,507
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 8,026,279

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Arbor Pharms Llc	HORIZANT	gabapentin enacarbil	TABLET, EXTENDED RELEASE;ORAL	022399-002	Dec 13, 2011		RX	Yes	No			Y	Y
Arbor Pharms Llc	HORIZANT	gabapentin enacarbil	TABLET, EXTENDED RELEASE;ORAL	022399-001	Apr 6, 2011		RX	Yes	Yes			Y	Y

International Family Members for US Patent 8,026,279

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	516801
Australia	2004282192
Brazil	PI0415288
Canada	2541752
China	1867322
Cyprus	1113583
Denmark	1677767